Overview: Government officials are becoming increasingly comfortable with legal medical marijuana, but remain reluctant to embrace adult use legalization. Canna Pro Series founders Greg Gershengorin and Bob Hoban discuss the Trump Administration’s first 100 days as they relate to marijuana policy, including the role of Sean Spicer and Jeff Sessions, and speculation that they spell the end of legal marijuana in the United States. But once the door is open, can legal marijuana sales truly be rolled back?
Overview of the differences between medical and adult use marijuana regulations and relevant federal law for each.
Understand which states are poised to stand up to the federal government in the face of increased federal enforcement over the tremendous tax revenue that they stand to lose
Discussion of the relationship of the pharmaceutical industry to the medical and adult use marijuana marketplaces; and the potential threat posed by the pharmaceutical lobby.
An overview of the “columns,” or potential markets, of the cannabis plant, including industrial hemp, medical/pharmaceutical cannabis distribution and the legal dispensary, nutraceutical market as well as the regulatory changes that would be required to enable and separate the three.
Discussion about the role between traditional conservative Republican political positions and the opportunity for education about the cannabis industry as it relates to economic growth and agricultural/industrial revival in the United States.
Preview of what is to come for emerging legal marijuana markets, such as California, where vague state regulatory schemes have ruled the day, but are quickly evolving and run the risk of leaving thousands of operators behind.
Presentation By: Robert T. Hoban, Esq., and Greg Gershengorin
Bob Hoban is the Managing Partner at Hoban Law Group, the nation's premier cannabusiness law firm, with attorneys in over a dozen states and abroad. Bob is recognized as one of the leading commercial cannabis practitioners nationwide; representing private and publicly-held clients in numerous states and abroad. He has litigated nearly every aspect of Colorado’s Marijuana Code and has closed over 300 marijuana-related business transactions. Marijuana and hemp-based business operations, related litigation and regulatory counsel are a specialty. He is an AV® Preeminent™ rated attorney and seasoned full-service commercial practitioner.
Bob is a professor at the University of Denver, in the Law and Society Program, and regularly instructs regarding government regulations, public policy, and research-based policy courses.
Furthermore, Bob has drafted more than 30 bills for the Colorado General Assembly (eminent domain/land use, hemp/marijuana and transportation).